Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEAD1 | P28347 | 3/20 | 0.42 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31345963 | 1.00 | TEAD1 (0.42) | TEAD1HTR1AFFAR1CYP19A1AR | |
| SCHEMBL31345984 | 0.88 | PNMT (0.35) | TEAD1HTR1AARHTR2BHTR2C | |
| SCHEMBL31346022 | 0.83 | FFAR1 (0.39) | TEAD1FFAR1 | |
| SCHEMBL31346038 | 0.82 | TERT (0.34) | TEAD1NPC1RAB9A | |
| SCHEMBL31346136 | 0.82 | CYP11B1 (0.40) | TEAD1 | |
| SCHEMBL31346060 | 0.82 | TERT (0.34) | TEAD1NPC1RAB9A | |
| SCHEMBL31346117 | 0.81 | CYP19A1 (0.45) | TEAD1HTR1AFFAR1CYP19A1DRD3 | |
| SCHEMBL31345995 | 0.81 | CYP19A1 (0.45) | TEAD1HTR1AFFAR1CYP19A1DRD3 | |
| SCHEMBL31346056 | 0.81 | TEAD1 (0.34) | TEAD1 | |
| SCHEMBL31346045 | 0.80 | TEAD1 (0.37) | TEAD1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |